PowerUp Acquisition (PWUP) Competitors $11.41 -0.03 (-0.26%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends PWUP vs. AMLX, TKNO, CYRX, YSB, AKBA, ZVRA, JSPR, FATE, ITOS, and QUREShould you be buying PowerUp Acquisition stock or one of its competitors? The main competitors of PowerUp Acquisition include Amylyx Pharmaceuticals (AMLX), Alpha Teknova (TKNO), Cryoport (CYRX), YS Biopharma (YSB), Akebia Therapeutics (AKBA), Zevra Therapeutics (ZVRA), Jasper Therapeutics (JSPR), Fate Therapeutics (FATE), iTeos Therapeutics (ITOS), and uniQure (QURE). These companies are all part of the "pharmaceutical products" industry. PowerUp Acquisition vs. Amylyx Pharmaceuticals Alpha Teknova Cryoport YS Biopharma Akebia Therapeutics Zevra Therapeutics Jasper Therapeutics Fate Therapeutics iTeos Therapeutics uniQure PowerUp Acquisition (NASDAQ:PWUP) and Amylyx Pharmaceuticals (NASDAQ:AMLX) are both small-cap unclassified companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, community ranking, earnings, analyst recommendations, institutional ownership, profitability, dividends, risk and media sentiment. Does the media favor PWUP or AMLX? In the previous week, Amylyx Pharmaceuticals had 2 more articles in the media than PowerUp Acquisition. MarketBeat recorded 3 mentions for Amylyx Pharmaceuticals and 1 mentions for PowerUp Acquisition. Amylyx Pharmaceuticals' average media sentiment score of 0.76 beat PowerUp Acquisition's score of 0.00 indicating that Amylyx Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PowerUp Acquisition 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Amylyx Pharmaceuticals 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is PWUP or AMLX more profitable? PowerUp Acquisition has a net margin of 0.00% compared to Amylyx Pharmaceuticals' net margin of -17.86%. PowerUp Acquisition's return on equity of 0.00% beat Amylyx Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets PowerUp AcquisitionN/A N/A N/A Amylyx Pharmaceuticals -17.86%-15.51%-12.86% Do analysts recommend PWUP or AMLX? Amylyx Pharmaceuticals has a consensus target price of $14.57, indicating a potential upside of 158.36%. Given Amylyx Pharmaceuticals' higher probable upside, analysts plainly believe Amylyx Pharmaceuticals is more favorable than PowerUp Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PowerUp Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AAmylyx Pharmaceuticals 0 Sell rating(s) 6 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.33 Does the MarketBeat Community believe in PWUP or AMLX? Amylyx Pharmaceuticals received 29 more outperform votes than PowerUp Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformPowerUp AcquisitionN/AN/AAmylyx PharmaceuticalsOutperform Votes2963.04% Underperform Votes1736.96% Do insiders and institutionals have more ownership in PWUP or AMLX? 19.2% of PowerUp Acquisition shares are owned by institutional investors. Comparatively, 95.8% of Amylyx Pharmaceuticals shares are owned by institutional investors. 48.0% of PowerUp Acquisition shares are owned by insiders. Comparatively, 11.7% of Amylyx Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has preferable earnings & valuation, PWUP or AMLX? Amylyx Pharmaceuticals has higher revenue and earnings than PowerUp Acquisition. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPowerUp AcquisitionN/AN/AN/AN/AN/AAmylyx Pharmaceuticals$380.79M1.01$49.27M-$2.45-2.30 SummaryAmylyx Pharmaceuticals beats PowerUp Acquisition on 7 of the 11 factors compared between the two stocks. Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Get PowerUp Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for PWUP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PWUP vs. The Competition Export to ExcelMetricPowerUp AcquisitionHolding Offices IndustryUnclassified SectorNASDAQ ExchangeMarket Cap$88.66M$418.28M$111.45M$8.53BDividend YieldN/A8.07%N/A4.14%P/E RatioN/A8.999.1315.14Price / SalesN/A99.659.47100.10Price / CashN/A74.9595.6034.08Price / BookN/A74.19525.095.02Net IncomeN/A$31.01M$2.17M$225.46M7 Day Performance-2.40%-0.90%-0.65%0.37%1 Month Performance-8.06%-0.51%-0.23%3.57%1 Year Performance5.06%11.58%15.41%29.43% PowerUp Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PWUPPowerUp AcquisitionN/A$11.41-0.3%N/A-3.3%$88.66MN/A0.00N/ANews CoveragePositive NewsAMLXAmylyx Pharmaceuticals4.0918 of 5 stars$5.33+0.4%$14.57+173.4%-67.0%$362.47M$298.76M-2.18200Positive NewsTKNOAlpha Teknova1.0115 of 5 stars$6.73-0.9%$5.00-25.7%+267.7%$358.71M$36.68M-7.24240Upcoming EarningsNews CoverageCYRXCryoport2.515 of 5 stars$7.18+4.2%$12.00+67.1%-24.9%$353.67M$225.61M-1.961,170Upcoming EarningsShort Interest ↑News CoverageYSBYS Biopharma1.4561 of 5 starsN/A$5.25+∞N/A$344.32M$560.76M0.00773AKBAAkebia Therapeutics4.0531 of 5 stars$1.63+2.5%$5.75+252.8%+91.6%$341.64M$174.50M-7.76167Short Interest ↓News CoverageZVRAZevra Therapeutics2.9026 of 5 stars$8.05+3.9%$20.83+158.8%+88.8%$336.92M$23.69M-4.7965Upcoming EarningsPositive NewsJSPRJasper Therapeutics3.4255 of 5 stars$22.02+12.6%$74.86+240.0%+210.4%$331.71MN/A-4.3220FATEFate Therapeutics3.633 of 5 stars$2.87+8.3%$6.90+140.4%+25.9%$326.70M$12.32M-1.68550Short Interest ↑Gap UpITOSiTeos Therapeutics3.0375 of 5 stars$8.93+2.4%$30.50+241.5%-11.1%$326.12M$12.60M-2.9890Upcoming EarningsQUREuniQure2.2854 of 5 stars$6.68+2.1%$19.50+191.9%+1.7%$325.32M$15.84M-1.13500Upcoming Earnings Related Companies and Tools Related Companies AMLX Competitors TKNO Competitors CYRX Competitors YSB Competitors AKBA Competitors ZVRA Competitors JSPR Competitors FATE Competitors ITOS Competitors QURE Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PWUP) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | Sponsored[Just Released] Jovine's Emergency Briefing insidePeople didn't believe Jovine when he predicted the 2008 financial crisis over a year in advance. But some read...Behind the Markets | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PowerUp Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share PowerUp Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
